(VIANEWS) – Walgreens Boots shares have surged 30.94% over 21 sessions.
Walgreens Boots (NASDAQ: WBA) experienced an unprecedented turnaround, seeing its shares jump 30.94% in just 21 sessions from November 30 to December 18 at 18:01 EST – this follows two consecutive days of losses! This astonishing turnaround came following two sessions where losses had occurred prior to this remarkable surge.
The wider market also experienced a decline, with the NASDAQ falling by 0.56% to EUR15,011.35. Walgreens Boots’ closing price of EUR26.11 represented an improvement compared to its 52-week low of EUR38.68; representing a reduction of 32.5% since that point.
This impressive rebound in stock price highlights both the company’s adaptability to market conditions, as well as their investors’ renewed faith in them.
About Walgreens Boots
Walgreens Boots Alliance, Inc. is an international healthcare, pharmacy, and retail company with operations in the US, UK, Germany and internationally. The company operates through three segments: US Retail Pharmacy; International; and US Healthcare. The US Retail Pharmacy segment encompasses drugstores, health and wellness services, specialty and home delivery pharmacy services. The International segment provides pharmaceutical and wellness products outside the US market and operates pharmacy-led retail businesses under Boots in various countries. VillageMD, Shields and CareCentrix of US Healthcare offer value-based care management, specialty pharmacy and post acute and home care management services respectively. Established in 1909 and based out of Deerfield Illinois.
Yearly Analysis
Based on an analysis of the data provided, Walgreens Boots’ current stock price of EUR26.11 represents an attractive investment opportunity for long-term investors who believe in its long-term prospects. However, investors should keep in mind that it also surpasses its 52-week low of EUR19.68.
This year’s sales growth forecast of 12% bodes well for investors. But next year’s expected decline to 4.3% may cause concern among some of them.
Walgreens Boots’s EBITDA of EUR148.91 indicates that it is producing significant profit, which should provide investors with confidence that this company is performing well and should consider other factors like debt levels, competition and overall market conditions before making their investment decision.
Technical Analysis
Walgreens Boots, a leading pharmacy-led health and wellbeing company, has seen fluctuations in its stock prices recently. At present, their current value exceeds both their 50-day moving average of EUR21.99 but still falls under their 200-day moving average of EUR27.66; suggesting short-term gains but yet to reach long-term average.
Walgreens Boots has reported a trading volume of 10,859,224 which is 12.77% lower than its average volume of 12,449,700 and indicates reduced trading activity compared to what would typically occur.
The stock’s volatility has remained fairly consistent over the last three time periods. The intraday variation average for last week, month and quarter were negative 0.11%, positive 1.30% and 2.10%, respectively; with its highest amplitude being recorded as 0.91% in each of these three time frames.
The stochastic oscillator, a widely-used indicator for measuring overbought and oversold conditions, has classified Walgreens Boots’ stock as overbought with an oscillator value greater than 80.
Walgreens Boots has experienced short-term gains, though it has yet to reach its long-term average. While trading volume and volatility remain relatively stable, its overbought status indicated by stochastic oscillator suggests investors be cautious in investing in this company.
Quarter Analysis
Equity Analysis
Walgreens Boots has an estimated forward annual dividend yield of 7.32%, which is relatively high compared to other companies in its industry. Unfortunately, its trailing twelve month earnings per share (EPS) are negative – suggesting it lacks profitability and its return on equity (ROE) is negative -11.98% – showing it’s failing at using investor money effectively to generate profits.
Investors should take into account several key criteria when assessing Walgreens Boots as an investment opportunity. Conduct further investigation on its financial health and future prospects before making any definitive investment decisions.
More news about Walgreens Boots (WBA).
